July 29-31, 2021 • Drs. Mario Sznol, Cath Bollard • Partner @sitcancer • Presented by @cec_onc • Grant: AstraZeneca
Houston, TX
Joined October 2016
- Tweets471
- Following207
- Followers402
- Likes543
IOYIF retweeted
Opioid Early Career Scholar Program
An intensive multi-day opioid REMS initiative in Pain Management
Register Today
Early Bird Deadline: February 14th
March 15-16, 2025
Wyndham Garden Lake Buena Vista
Buena Vista, FL
@cmeoutfitters #health #wellness
IOYIF retweeted
Keeping these young investigators engaged & supported in their important work gives patients continued hope for a better tomorrow. Our future depends on progress. We are thankful for these mentors and this platform! @EGFRSummit #ResearchMatters #anyonewithlungs
Watch now - EGFR Resisters 5th Annual Research Summit Wrap Up w/ commentary from @StephenVLiu & @ivybelkins.
Congratulations to the young investigators! Thank you @CE_Concepts for sponsoring this event!
@EGFRSummit #lcam #lcsm
youtube.com/watch?v=tniPDAyA…
IOYIF retweeted
cmepalooza.com/live/ @cmeoutfitters #MedEd #MedTwitter #healthcare Learn more about what makes CME education different from other routes of learning.
Looking to present your research??
Submit your abstract for the #ALLYIF 2023!
📈 Improve your #Research Skills
🏆 Research awards range from $1k-$4k
DEADLINE to submit is OCTOBER 15➡ ce.ceconcepts.com/ALLYIF
#HematologyResearch #OncologyResearch
Look at who ran into each in the wild at #ASCO23? 2⃣ fantastic #IOYIF21 alumni! @BraunMDPhD @thenasheffect 🙌
Immuno-oncology Young Investigators! Join us LIVE online or in-person at #SITC22 Nov 11th at 6:00pm ET & earn 1.0 CME Credit!
Our faculty panel will discuss the power of immunotherapy in HCC & BTC!
Register for in-person/online here ➡️ ce.ceconcepts.com/SITC22
IOYIF retweeted
Extremely grateful @BWFUND for the support!!! Also thankful for the amazing mentorship, it really makes a difference. Also congrats to all the fellow awardees!
The Burroughs Wellcome Fund is pleased to announce the recipients of the 2022 Career Award for Medical Scientists buff.ly/3GGFRZL
#bwfcams #bwfrtp
Excited to see so many @IOYIForum faculty & alums involved with this @sitcancer series! @MSznol @Vignali_Lab @BcellBruno @aaronmring #LAG3 #IL18 #TIL #Bcell
sitcancer.org/education/webi…
Shout out to an amazing @IOYIForum alum, @thenasheffect! 🎉🎉
Honored to be part of and learn from this group of featured voices @ASCO. Will try my best to highlight #ASCO22 sessions on Dev Therapeutics/ IO Biomarkers/ irAEs/ Lung. @ShannonWestin @neerajaiims @DrBetofMDPhD @crisbergerot @AnaVManana @fumikochino @IshwariaMD others
IOYIF retweeted
Honored to be included as an ASCO YIA recipient this year for my work on systemic inflammation in people experiencing #lymphedema following breast cancer tx!
Also so happy to be sharing this experience with @OSUCCC_James co-fellows @JasmineSukumar & Nate Denlinger!
#ASCO22 is less than two weeks away, and we’ll be awarding more than $12 million in support to these and other incredible cancer researchers! Special thanks to Conquer Cancer donors, and congratulations to the recipients of our 2022 Grants & Awards! #cancerresearch #oncology
IOYIF retweeted
The Center of Molecular and Cellular Oncology (CMCO) @YaleMed @YaleCancer is hiring a Program Manager!
bit.ly/YaleCareers-73472BR
Congrats to our alumni and awardee, @BraunMDPhD! 🎉 #IOYIF21
David Braun, MD, PhD, Joins Prostate and Urologic Cancers Program at Yale Cancer Center ascopost.com/issues/may-10-2… @YaleCancer @BraunMDPhD
Congrats @thenasheffect on the nomination! Proud to see our alums being recognized! Be sure to congratulate Dr. Naquash at ASCO! 🙌🙌🙌
Deeply honored to have been nominated and selected for 2022 class of #40 under #40 in Oncology 🙂 @StephensonCC @OUHealth @sitcancerECS
Join us for the reception and ceremony on June 4 #ASCO22 😊
IOYIF retweeted
Thank you #AACR2022 for an incredible week of science, friends and food. You even brought #Tcells and #macrophages together.
Heard among friends in this photo: “it’s not all about the Tcell”. @JimAllisonPhD @MiriamMerad @PamSharmaMDPhD
IOYIF retweeted
So excited to see FDA approval of the first anti-LAG3, in combination with anti-PD1! It has been a long road but we have had the pleasure of working with an amazing team of trainees and collaborators dissecting LAG3 function since ~2020 (20+ papers)! 1/2 news.bms.com/news/details/20…
IOYIF retweeted
Out in @NEJM this week, our perspective on some recent outstanding work defining the phenotype of tumor-infiltrating T cells across cancer types, and our thoughts on next steps.
Tumor-Infiltrating T Cells — A Portrait | NEJM nejm.org/doi/full/10.1056/NE…
@YaleCancer @YaleMed
IOYIF retweeted
We would like to extend a THANK YOU to Rosemary Ostmann from @rosecomm & @ivybelkins from @EGFRResisters for sharing all of their insights on best practices to becoming a digital opinion leader during last Friday’s webinar. 💻🔎
See a few of the topics below! #DOL #MedTwitter
Our webinar on best practices to becoming a digital opinion leader is this Fri 1/21 @ 12p!
Reply to this tweet w/ your Q's on best practices as a trusted source & hear from communications expert @rosecomm answer your Q's.
Click ⬇️ & reserve your spot!
ce.ceconcepts.com/YI
Hey YIF Alums!
What are you most curious about in becoming a trusted source for science in the age of digital media? 🤔Join us on Fri 1/21 @ 12p to see how you can increase the reach of your research.🌐
Click ⬇️to register for this can’t miss session!
ce.ceconcepts.com/YI
